Results 61 to 70 of about 1,553,841 (335)

Tumors in von Hippel–Lindau Syndrome: From Head to Toe—Comprehensive State-of-the-Art Review [PDF]

, 2018
Von Hippel–Lindau syndrome (VHL) is an autosomal-dominant hereditary tumor disease that arises owing to germline mutations in the VHL gene, located on the short arm of chromosome 3.
Bhalla, Sanjeev, Ganeshan, Dhakshinamoorthy, Lubner, Meghan G., Menias, Christine O., Pickhardt, Perry J., Ramalingam, Preetha, Sandrasegaran, Kumaresan   +6 more
core   +1 more source

Capecitabine and temozolomide combination for treatment of high-grade well-differentiated neuroendocrine tumour and poorly-differentiated neuroendocrine carcinoma. Retrospective analysis.

Endokrynologia Polska, 2019
INTRODUCTION Many retrospective studies confirmed that capecitabine combined with temozolomide is effective in treatment of neuroendocrine neoplasm. Most of studies focused on grade 1 and grade 2 neuroendocrine tumours, mainly of pancreas origin.
W. Rogowski, E. Wachuła, Anita Gorzelak, Aneta Lebiedzińska, Violeta Sulżyc-Bielicka, E. Iżycka-Świeszewska, J. Zolnierek, B. Kos-Kudła   +7 more
semanticscholar   +1 more source

Gastric neuroendocrine carcinoma with positive staining for prostate cancer markers including prostate-specific antigen and alpha-methylacyl-CoA racemase

Urology Case Reports, 2018
We report a case with prostate cancer and gastric neuroendocrine carcinoma. A 72-year old male presented with a gastric lesion 5 months after radical prostatectomy.
Yuji Hakozaki, Taro Murata, Munehiro Yokoyama, Hisashi Matsushima, Maki Ogawa, Tomoko Masuda, Yoko Hirai, Haruki Kume   +7 more
doaj   +1 more source

Targeting hypoxia-inducible factor-1α (HIF-1α) in combination with antiangiogenic therapy: a phase I trial of bortezomib plus bevacizumab. [PDF]

, 2014
PurposeWe hypothesized that bortezomib, an agent that suppresses HIF-1α transcriptional activity, when combined with bevacizumab, would obviate the HIF-1α resistance pathway.
Amin, Hesham M, Angelo, Laura S, Falchook, Gerald S, Hess, Kenneth, Hong, David, Howard, Adrienne N, Huang, Mei, Jackson, Edward F, Janku, Filip, Kurzrock, Razelle, Lawhorn, Kristie N, Naing, Aung, Ng, Chaan S, Parkhurst, Kristin L, Tannir, Nizar M, Vishwamitra, Deeksha, Wheler, Jennifer J   +16 more
core   +2 more sources

Cutaneous metastasis of neuroendocrine carcinoma

Indian Journal of Dermatology, 2013
The skin is a relatively uncommon site for distant metastatic deposits, compared with organ such as liver, bone, and lung. The most common sources of cutaneous metastases are: Breast, lung, colon, stomach, upper aeridigestive tract, uterus and kidney.
Catharina Fluehler, Laura Quaranta, DI MEO, NICOLA, Bruno Ulessi, TREVISAN, GIUSTO   +4 more
openaire   +4 more sources

FOXA2 is a Sensitive and Specific marker for Small Cell Neuroendocrine Carcinoma of the Prostate

Modern Pathology, 2017
The median survival of patients with small cell neuroendocrine carcinoma is significantly shorter than that of patients with classic acinar-type adenocarcinoma.
J. Park, John K. Lee, O. Witte, Jiaoti Huang   +3 more
semanticscholar   +1 more source

Prognosis of Poorly-differentiated Gastric Neuroendocrine Neoplasm

Zhongliu Fangzhi Yanjiu, 2019
Objective To explore the effects of clinicopathological features and adjuvant therapy on the prognosis of patients with poorly-differentiated gastric neuroendocrine tumors.
ZHANG Jian, ZANG Fenglin, ZHANG Jiali, ZHANG Xinwei   +3 more
doaj   +1 more source

Correlation of Matrix Metalloproteinases and Tissue Inhibitors of Matrix Metalloproteinase Expression in Ileal Carcinoids, Lymph Nodes and Liver Metastasis with Prognosis and Survival [PDF]

, 2009
Purpose: Ileal carcinoids are gut epithelial tumors originating from serotonin-containing enterochromaffin (EC) cells. Therapeutic options for effectively inhibiting the growth and spread of metastatic carcinoids are still limited.
Baur, Dorothee M., Besig, Sophie, Braun, Thomas, Hoefler, Heinz, Langer, Rupert, Perren, Aurel, Prinz, Christian, Rad, Roland, Voland, Petra   +8 more
core   +2 more sources

Metastatic small cell neuroendocrine carcinoma of the cervix treated with the PD-1 inhibitor, nivolumab: a case report

Gynecologic Oncology Research and Practice, 2017
BackgroundNivolumab is an immune checkpoint inhibitor specific for the programmed death 1 (PD-1) receptor that has led to clinical responses in many cancer types.
S. Paraghamian, T. Longoria, R. Eskander
semanticscholar   +1 more source

Neuroendocrine breast carcinoma: a rare but challenging entity

Medical Oncology, 2020
Breast carcinoma with neuroendocrine differentiation, also known as neuroendocrine breast carcinoma (NEBC), includes a heterogeneous group of rare tumors, which account for 2–5% of all invasive breast carcinomas.
Elena Trevisi, A. La Salvia, L. Daniele, M. Brizzi, G. De Rosa, G. Scagliotti, M. Di Maio   +6 more
semanticscholar   +1 more source